افق دارو

Formodil

Ofogh Darou Company, by utilizing the best ingredients and employing the most advanced machinery, has successfully produced Fermodil in Iran. This company, as the first and most fully equipped DPI (Dry Powder Inhaler) production line in the country, has been able to introduce a product to the market that was previously available only through import, imposing high costs on the healthcare system and patients.

The specialized DPI production machinery at Ofogh Darou is capable of measuring the exact amount of active ingredient in each capsule with very high precision. This high measurement accuracy represents a significant advancement in the country’s pharmaceutical industry.

By leveraging advanced laboratory equipment and specialized training for its personnel, Ofogh Darou has obtained accreditation from the Food and Drug Organization. As the only laboratory partner in the field of respiratory products, it is able to perform all specialized tests and quality control procedures for these medications within Iran.

This achievement is not only a major step toward the country’s pharmaceutical self-sufficiency but also enhances the confidence of patients and physicians in the quality and safety of domestically produced products.

Product Information

Drug Name: Formodil

Pharmacological Class: Long-acting beta-adrenergic receptor agonist (LABA)

Drug Effect: Rapid-onset and long-acting

Dosage Form: Dry Powder Inhalation Capsule (DPI)

Dose per Capsule: Each capsule contains 25 mg of formulation, including 12 µg of formoterol as the active ingredient

Age Group: Adults and adolescents over 12 years old

Indications

Indications

  • Treatment of asthma in combination with inhaled corticosteroids

  • Prevention of exercise-induced bronchospasm

  • Maintenance therapy in all stages of COPD

Mechanism of Action

Formodil relaxes the muscles surrounding the airways, opening the passages and making breathing easier while reducing the feeling of shortness of breath. When used alongside inhaled corticosteroids, it helps control airway inflammation, reduces the frequency of asthma attacks, and helps maintain optimal lung function.

The combination of these effects provides long-term control of asthma and COPD symptoms and reduces the need for rapid-acting medications during acute episodes.

Important Notes Before and During Use

  • Capsules should only be used with the designated inhalation device.

  • This medication is not intended for the treatment of acute respiratory attacks.

  • Use in children is only permitted under a physician’s prescription.

  • Ensure correct usage of the inhalation device.

Warnings

Possible Side Effects

Common (may occur in some patients)

  • Dry mouth

  • Mild cough

  • Hoarseness or scratchy throat

Less Common

  • Mild dizziness

  • Sinus pain

  • Eye irritation or dryness

  • Unusual taste in the mouth

  • Headache

  • Hand tremors

  • Mild palpitations

Rare but Serious

  • Allergic reactions (e.g., swelling of the tongue, lips, face, or severe shortness of breath)

If any rare or serious side effects occur, the patient should immediately contact a physician for appropriate medical action.

Storage Instructions
Store at room temperature, away from light and moisture.

  • Remove capsules from the packaging only immediately before use.

  • Keep out of reach of children.

Frequently Asked Questions (FAQ)

Yes, Formodil is generally used together with inhaled corticosteroids. However, co-administration must always be under a physician’s supervision to prevent potential drug interactions.

Take the missed dose as soon as you remember. Do not take a double dose to make up for the missed one.

Use of this medication is only allowed under a doctor’s supervision. The doctor must evaluate the risks and benefits before prescribing it in these conditions.

Formodil is not recommended for children, unless specifically prescribed by a doctor. This medication is primarily intended for adults and adolescents over 12 years old.